M. Lauricella et al., Synergistic cytotoxic interactions between sodium butyrate, MG132 and camptothecin in human retinoblastoma Y79 cells, TUMOR BIOL, 21(6), 2000, pp. 337-348
This paper studies the effects caused in human retinoblastoma Y79 cells by
treatment with combinations of sodium butyrate, the inhibitor of topoisomer
ase I camptothecin and the inhibitor of 26S proteasome MG132. The combinati
on of sodium butyrate and camptothecin resulted in a strong synergistic cyt
otoxicity, as revealed by combination indices of 0.77 and 0.52 calculated a
t IC50 and IC75 Synergistic interactions were also demonstrated for combina
tions of sodium butyrate and MG132, camptothecin and MG132 and for a combin
ation of all three compounds. The cytotoxic effects observed after the comb
ined treatments can be considered a consequence of apoptosis, as suggested
by the appearance of morphological signals of apoptosis and by the activati
on of caspase-3 with degradation of poly-ADP ribose polymerase and lamin B.
Treatment of Y79 cells with sodium butyrate alone lowered the levels of p5
3, E2F-1 and Bcl-2. The addition of MG132 to sodium butyrate counteracted t
he effect on p53 only, while the addition of camptothecin to sodium butyrat
e counteracted the effect on both p53 and E2F-1. The treatment of Y79 cells
with the triple combination increased the level of p53, decreased that of
Bcl-2, while the level of E2F-1 was not modified. We suggest that the effec
ts exerted on the levels of these regulatory proteins can explain the syner
gistic interactions demonstrated between sodium butyrate, camptothecin and
MG132. Copyright (C) 2000 S. Karger AG. Basel.